Big pharma pushes for European policy change as tariffs loom
Leveraging Trump’s impending tariffs, pharma companies have called on Europe again to change regulation, threatening a US exodus.
Business & Regulation
RFK Jr shifts stance on MMR vaccine amid measles deaths
Sacklers to pay up to $7bn in Purdue Pharma’s opioid settlement plan
Biosimilars drive Sandoz growth ahead of unclear tariff effects in 2025
Idorsia’s Tryvio deal collapses, forcing company to find cash urgently
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Valneva hits 2024 sales target but plans lower cash burn in 2025
Trump’s tariffs could strain medicine supply and drive drug costs
